Cancer Models Forum

Posted by Repositive, April 2019

The key factors every biopharma should consider when planning their preclinical cancer model requirements

Selecting the right preclinical cancer model and contract research organisation (CRO) for your drug development programme is critical to its success.

To help you find the right cancer model and CRO partner for your research, we’ve put together a helpful checklist of the key factors you should consider when planning your next project.

Preclinical cancer model requirements checklist of the key factors pharma and biotech should consider when planning their next preclinical cancer drug development project. Includes model type, genomic and molecular characteristics and drug response data

Preclinical cancer model requirements checklist of the key factors pharma and biotech should consider when planning their next preclinical cancer drug development project. Includes model type, genomic and molecular characteristics and drug response data 1

Wow! There is a lot to consider when planning your preclinical drug development programme (and a lot at stake if you don’t choose the best available model for your research).

Need some assistance? Why not use our expert, tailored and confidential Cancer Models Scout service to help you source the preclinical cancer model you need.

Learn more CTA button

Image credit: ©BillionPhotos.com - stock.adobe.com

Posted by
Repositive

Repositive

Repositive Press Team
See all Repositive's posts